Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months [Phase 3]
Phase 3 trial evaluating avatrombopag for thrombocytopenia in pediatric patients with immune thrombocytopenia for at least 6 months complete…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months [Phase 3]
Phase 3 trial evaluating avatrombopag for immune thrombocytopenia in pediatric patients completed with results posted.
-
FDA approval · 2025-01-17FDA Approved: ELTROMBOPAG — Original Application (XLCare Pharmaceuticals Inc.)
FDA approves a generic eltrombopag product under an original application (ANDA 206788) submitted by XLCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim [Phase 4]
Phase 4 trial updating safety and treatment satisfaction after switching adults with chronic immune thrombocytopenia to avatrombopag from el…
-
CLINICAL_TRIALS trial_result · 2024-12-30Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia [Phase 2]
Phase 2 randomized, double-blind, placebo-controlled, multi-center trial evaluating CM313 for immune thrombocytopenia; currently ACTIVE_NOT_…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Longitudinal Cohort of Thrombosis and Hemostasis Diseases
A longitudinal cohort clinical trial in China studying thrombosis and hemostasis diseases. It is currently recruiting at Peking University P…
-
CLINICAL_TRIALS research · 2024-12-04Clinical Trial Update: Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia [NA]
Clinical trial update examining whether acute phase proteins can aid in diagnosing immune thrombocytopenia. The study NCT06715215 is current…
-
EMA approval · 2024-12-02EMA Authorised: Tavlesse (Fostamatinib disodium) — Instituto Grifols S.A.
EMA authorised Tavlesse (fostamatinib disodium) for thrombocytopenia, with Instituto Grifols S.A. as the marketing authorisation holder; dec…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Outcome Study of Conventional Steroids Vs. Steroids Combined with Mycopehnolate in Newly Diagnosed Immune Thrombocytopenia Purpura. [Phase 3]
Phase 3 trial comparing conventional steroids versus steroids combined with mycophenolate mofetil in newly diagnosed immune thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of subcutaneous efgartigimod PH20 in adults with primary immune thrombocytopenia has comp…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP [Phase 2]
A Phase 2 clinical trial is evaluating romiplostim as a first-line treatment for newly diagnosed adults with Primary Immune Thrombocytopenia…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Immunomodulation With Eltrombopag in ITP [Phase 2]
A Phase 2 clinical trial evaluating immunomodulation with eltrombopag in primary immune thrombocytopenia has completed. The study was sponso…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Prospective Evaluation of Diagnosis and Treatment of Patients With Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia, Immune Thrombocytopenia, and Chronic Idiopathic/Autoimmune Neutropenia
This clinical trial update describes a prospective evaluation of diagnosis and treatment among patients with autoimmune cytopenias, includin…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults [Phase 3]
A Phase 3 clinical trial evaluating intravenous immunoglobulin (Bioven) for efficacy and safety in adults with chronic primary immune thromb…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy [Phase 2]
A Phase 2 trial evaluating prednisone alone versus prednisone plus intravenous immunoglobulin for immune thrombocytopenia during pregnancy i…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: The Outcome of the Thrombopoietin Receptor Agonists in Pediatric Patient With Persistent or Chronic ITP Unresonsive to Steroids [NA]
This clinical trial update notes an ongoing pediatric study evaluating thrombopoietin receptor agonists for persistent or chronic immune thr…
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Observatory of Immunological Thrombopenic Purpura in the Brest Region
A recruiting ClinicalTrials.gov study in Brest investigating immune thrombocytopenia (immune thrombocytopenia/ITP).
-
CLINICAL_TRIALS trial_result · 2024-08-12Clinical Trial Update: The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects [Phase 1]
Phase 1 study assesses the safety and tolerability of a subcutaneous dose of STSA-1301 in healthy subjects; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial evaluating PANZYGA in pediatric Chronic Immune Thrombocytopenia has been terminated; results were posted in 2024.
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: IASO-782 in Autoimmune Hematological Diseases [Phase 1]
Phase 1 clinical trial update for IASO-782 in autoimmune hematological diseases, including immune thrombocytopenia and autoimmune hemolytic …
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP) [Phase 4]
Phase 4 trial evaluating adding an anti-CD20 monoclonal antibody to thrombopoietin receptor agonists for pediatric immune thrombocytopenia, …
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP) [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and efficacy of CAR-T cell therapy for chronic or refractory primary immune thrombocytop…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients [Phase 1]
This Phase 1 study reports safety, tolerability, pharmacokinetics and preliminary efficacy of HMPL-523 in patients with immune thrombocytope…
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Human Mass Balance of [14C]HMPL-523 in Healthy Adult Male Chinese Subjects [Phase 1]
Phase 1 mass-balance pharmacokinetics study of [14C]HMPL-523 in healthy adult male Chinese subjects completed, sponsored by Hutchmed.
-
CLINICAL_TRIALS trial_result · 2024-07-11Clinical Trial Update: Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia [Phase 3]
Phase 3 study of GP40141 in immune thrombocytopenia is ongoing, with a focus on efficacy, safety, and immunogenicity; current status is ACTI…